-
-
-
-
-
-
-
Piper Sandler Starts Relmada Therapeutics Inc (RLMD) at Overweight
-
-
-
-
-
-
-
Relmada gets FDA alignment on NDV-01 bladder cancer trial designs
-
-
-
-
-
-
-
Sidoti Events, LLC's Virtual September Small-Cap Conference
-
-
-
-
-
-
-
Relmada Therapeutics (RLMD) Presents Positive Initial Phase 2 NDV-01 Data
-
-
-
-
-
-
-
Leerink Partners Downgrades Relmada Therapeutics Inc (RLMD) to Market Perform
-
-
-
-
-
-
-
Relmada Therapeutics (RLMD) Tops Q2 EPS by 24c
-
417,514 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

